dcvax-l
northwest biotherapeutics
['gbm', 'dcvax', 'nwbo']
in #gbm, 417 trials involving &gt;31k patients have tried to show positive results. only 16 have reached phase iii. but $nwbo s dcvax-l has now provided the best survival rates ever seen against gbm, with minimal side-effects. watch the presentation. 
News, technology, medicine & opinion from internet entrepreneur, physical geographer, and former school board member.